From Orchard’s Lenmeldy to Vertex and CRISPR Therapeutics’s Casgevy, Pharmaceutical Technology lists the top ten priciest ...

C1QL1 promotes the replacement of the cells that produce myelin. Boosting it may improve treatment of demyelinating diseases.

Research in zebrafish and mouse models reveals targeting EGLN2 could potentially reduce inflammation and slow down the progression of ALS.

Motor neuron diseases are a group of progressive and ultimately fatal neurodegenerative disorders of the motor system, ...

Astrocytes in the brain exhibit significant regional diversity, but the mechanisms controlling their heterogeneity remain ...

Altogether, these findings demonstrate that the PRMT1-SFPQ pathway regulates intron retention in CNCCs and suggests intron retention in long introns or long genes as a mechanism that controls matrix ...